MDK-4204 Inhibitor

MDK-4204, an anticancer agent, shows significant anti-cancer activity with IC50 values of 8.8uM and 9.5uM in PC-3 and DU-145 cells, respectively.

ef="javascript:void(0) rel="nofollow >
1 Miyak H Ima S Tamur K Sugiyam T Furus H Ozon S Fujisaw M Compariso o Tyrosin Kinas Inhibito Versu Mammalia Targe o Rapamyci Inhibito a Second-lin Molecular-targete Therap fo Patient wit Poor-ris Metastati Rena Cel Carcinoma Anticance Res 201 Mar 7(3):1523-1528 PubMe PMID 28314328 href="javascript:void(0) rel="nofollow >
2 Arvaniti CD Bazan-Peregrin M Rifa B Seymou LW Coussio CC Cavitation-enhance extravasatio fo dru delivery Ultrasoun Me Biol 201 Nov 7(11):1838-52 doi 10.1016/j.ultrasmedbio.2011.08.004 Epu 201 Oc 2 PubMe PMID 21963037 href="javascript:void(0) rel="nofollow >
3 Bec R Dejean N Glorieu C Pedros RC Vásque D Valderram JA Caldero PB Verra J Molecula chaperon Hsp9 a targe fo oxidant-base anticance therapies Cur Me Chem 2011 8(18):2816-25 Review PubMe PMID 21568884 href="javascript:void(0) rel="nofollow >
4 Ah S Kearbe JD L CM Duk C 3rd Mille DD Dalto JT Biotransformatio o nove antimitoti agent I-387 b mouse rat dog monkey an PUMA live microsome an i viv pharmacokinetic i mice Dru Meta Dispos 201 Apr 9(4):636-43 doi 10.1124/dmd.110.036673 Epu 201 Ja 13 PubMe PMID 21233217.

Small volumes of MDK-4204, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5777697 is an inhibitor targeting MDK-4204.